Citation and Traceability for Bioequivalence R&D Document

Data Characteristics

Bioequivalence (BE) research and development (R&D) documents include study protocols, clinical trial reports, analytical method validation reports, and statistical analysis reports. Data sources are internal pharmaceutical company R&D management systems, CRO (Contract Research Organization) reports, and regulatory guidelines. These documents have a low update frequency, typically revised at project milestones or due to regulatory requirements. Document structures are complex, often containing numerous tables, charts, and embedded attachments. Text sections are rich in specialized terminology, covering pharmacokinetic parameters (e.g., AUC, Cmax, Tmax), statistical indicators (e.g., confidence intervals, coefficients of variation), and bioanalytical data. Fields and units adhere to strict industry standards; for example, AUC units are often ng·h/mL, Cmax units are ng/mL, and confidence intervals are typically expressed as 90%.

Constraints on Citation and Traceability

The low update frequency of BE R&D documents means knowledge base content is relatively stable, with low real-time requirements but extremely high accuracy demands. Complex structures and dense specialized terminology mean traditional text segmentation can break critical information, requiring refined preprocessing strategies. The presence of numerous tables, charts, and embedded attachments means pure text indexing cannot capture all semantics, requiring enhanced parsing capabilities. For example, accurate extraction of pharmacokinetic and statistical parameters, and their contextual relationships, directly impacts the effectiveness of citation traceability. Strict field and unit specifications require citations to be precise down to the numerical value and its unit to avoid ambiguity. Any citation deviation can lead to incorrect R&D decisions or regulatory non-compliance. Therefore, precise pointing of citation sources and clear traceability paths are crucial. Retrieval results must link directly to specific paragraphs or data tables in the original document.

Configuration Settings

Configuration Item	Recommended Value	Rationale
`Chunk size` (Chunk Size)	`300–500 characters` (characters)	Balances contextual completeness of specialized terms with retrieval efficiency. Avoids overly long chunks leading to information redundancy or overly short chunks causing semantic fragmentation.
`Chunk Overlap Length` (Overlap Size)	`100 characters` (characters)	Ensures critical information spanning across chunks is effectively recalled, especially for sections involving parameter definitions or statistical interpretations.
`Recall count` (Recall Count)	`Top 5–8 entries` (top 5–8 items)	Given the high density of document content, increasing the recall count helps cover more potentially relevant paragraphs, improving traceability accuracy.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	Strictly controls similarity to ensure recalled results are highly relevant to the query intent, reducing inaccurate or irrelevant content citations.
`Rerank result count` (Reranked Return Count)	`Top 3 entries` (top 3 items)	Based on high-similarity recall, reranking further optimizes result order, focusing on the three most relevant items for citation.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds` (seconds)	Ensures sufficient time for file parsing when processing large clinical trial reports or method validation reports, preventing timeouts.

Three Common Mistakes

Answers do not precisely cite the original text from the knowledge base, but instead provide AI summaries or paraphrases. This leads to inaccuracies in critical data such as pharmacokinetic parameters or statistical confidence intervals. This occurs if the Similarity threshold (Similarity Threshold) is set too low or Recall count (Recall Count) is insufficient, giving the model too much freedom in generation.
After AI queries the database in a workflow, the answer does not cite the query results, or the cited source file link is empty. This happens if the knowledge base index does not correctly associate with the original file path, or if the Citation Source feature is not enabled or configured incorrectly, preventing the generation of clickable traceability links.
In the code execution node, citation information from the knowledge base is unavailable. For example, if the goal is to output the document ID or page number of the first search result. This occurs if the knowledge base query node's output variables do not include detailed citation metadata (such as source_id or page_number), or if subsequent nodes do not correctly parse these variables.

How to Verify Configuration

Ask questions about core pharmacokinetic parameters (e.g., AUC, Cmax) or key statistical indicators (e.g., 90% confidence interval). Check if the answer accurately cites values and units from the original document and can be traced to the specific page or paragraph.
Upload a BE report containing complex tables and embedded charts. Ask questions about specific data points within the tables or charts. Verify that the system correctly parses and cites the corresponding table row or chart description.
Try a query containing synonyms or abbreviations (e.g., "Bioavailability" and "BA", "Cmax" and "Peak concentration"). Verify that the system can recall relevant documents through semantic matching and provide accurate citation sources.
Check the indexing status after adding documents to the knowledge base. Ensure all BE R&D documents have been successfully parsed and indexed, with no parsing failed or indexing abnormal messages.

The values given are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.